Joseph H. Wender, Director at IONIS PHARMACEUTICALS INC (IONS), sold 29,600 shares at $45.79 ($1.3M) on 2018-05-11, disclosed to the SEC on 2018-05-11.
Open-market sale of $1.3M IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.02 | 400 | $18K | 1.3% |
| 2 | $45.03 | 8,590 | $387K | 28.8% |
| 3 | $45.03 | 8,590 | $387K | 28.8% |
| 4 | $45.79 | 6,010 | $275K | 20.5% |
| 5 | $45.79 | 6,010 | $275K | 20.5% |
| Total | $45.32 avg | 29,600 |
| $1.3M |
| 100% |
| Filing → |
| IONS | SELL | 2025-10-02 | $1.1M | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.6M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |